1. Academic Validation
  2. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus

Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus

  • J Hum Genet. 2005;50(6):283-292. doi: 10.1007/s10038-005-0253-9.
Shiro Maeda 1 Shuichi Tsukada 2 Akio Kanazawa 2 Akihiro Sekine 3 Tatsuhiko Tsunoda 4 Daisuke Koya 5 Hiroshi Maegawa 5 Atsunori Kashiwagi 5 Tetsuya Babazono 6 Masafumi Matsuda 7 Yasushi Tanaka 8 Tomoaki Fujioka 9 Hiroshi Hirose 10 Takashi Eguchi 10 Yoichi Ohno 10 Christopher J Groves 11 12 Andrew T Hattersley 13 Graham A Hitman 14 Mark Walker 15 Kohei Kaku 7 Yasuhiko Iwamoto 6 Ryuzo Kawamori 8 Ryuichi Kikkawa 5 Naoyuki Kamatani 16 17 Mark I McCarthy 11 12 Yusuke Nakamura 17 18
Affiliations

Affiliations

  • 1 Laboratory for Diabetic Nephropathy, SNP Research Center, The Institute of Physical and Chemical Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan. smaeda@src.riken.jp.
  • 2 Laboratory for Diabetic Nephropathy, SNP Research Center, The Institute of Physical and Chemical Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.
  • 3 Laboratory for Genotyping, SNP Research Center, The Institute of Physical and Chemical Research, Kanagawa, Japan.
  • 4 Laboratory for Medical Informatics, SNP Research Center, The Institute of Physical and Chemical Research, Kanagawa, Japan.
  • 5 Department of Medicine, Shiga University of Medical Science, Shiga, Japan.
  • 6 Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
  • 7 Division of Endocrinology and Metabolism, Department of Internal Medicine, Kawasaki Medical School, Okayama, Japan.
  • 8 Department of Medicine, Metabolism and Endocrinology, School of Medicine, Juntendo University, Tokyo, Japan.
  • 9 Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan.
  • 10 Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • 11 Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK.
  • 12 Wellcome Trust Centre for Human Genetics, Oxford, UK.
  • 13 Centre for Molecular Genetics, Peninsula Medical School, Exeter, UK.
  • 14 Centre of Diabetes and Metabolic Medicine, Bart's and The London, Queen Mary's School of Medicine and Dentistry, London, UK.
  • 15 School of Clinical Medical Sciences, University of Newcastle, Newcastle, UK.
  • 16 Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
  • 17 Research Group for Personalized Medicine, SNP Research Center, The Institute of Physical and Chemical Research, Kanagawa, Japan.
  • 18 Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Abstract

To search a gene(s) conferring susceptibility to type 2 diabetes mellitus, we genotyped nearly 60,000 gene-based SNPs for Japanese patients and found evidence that the gene at chromosome 6p12 encoding transcription-factor-activating protein 2beta (TFAP2B) was a likely candidate in view of significant association of polymorphism in this gene with type 2 diabetes. Extensive analysis of this region identified that several variations within TFAP2B were significantly associated with type 2 diabetes [a variable number of tandem repeat locus: chi(2)=10.9, P=0.0009; odds ratio=1.57, 95% CI 1.20-2.06, intron 1+774 (G/T); chi(2)=11.6, P=0.0006; odds ratio=1.60, 95% CI 1.22-2.09, intron 1+2093 (A/C); chi(2)=12.2, P=0.0004; odds ratio=1.61, 95% CI 1.23-2.11]. The association of TFAP2B with type 2 diabetes was also observed in the UK population. These results suggest that TFAP2B might be a new candidate for conferring susceptibility to type 2 diabetes and contribute to the pathogenesis of type 2 diabetes.

Figures